Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reimbursement issues in diabetes.

P Sinnock, D W Bauer

    Diabetes Care
    |May 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Securing third-party reimbursement for diabetes outpatient education and new technologies remains challenging. Navigating payer policies is crucial for accessing vital diabetes management services and equipment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Influence of Internal DNA Pressure on Stability and Infectivity of Phage λ.

    Journal of molecular biology·2015
    Same author

    Exploring the Balance between DNA Pressure and Capsid Stability in Herpesviruses and Phages.

    Journal of virology·2015
    Same author

    Harpin induces disease resistance in Arabidopsis through the systemic acquired resistance pathway mediated by salicylic acid and the NIM1 gene.

    The Plant journal : for cell and molecular biology·1999
    Same author

    A cloned Erwinia chrysanthemi Hrp (type III protein secretion) system functions in Escherichia coli to deliver Pseudomonas syringae Avr signals to plant cells and to secrete Avr proteins in culture.

    Proceedings of the National Academy of Sciences of the United States of America·1998
    Same author

    The hrpC and hrpN operons of Erwinia chrysanthemi EC16 are flanked by plcA and homologs of hemolysin/adhesin genes and accompanying activator/transporter genes.

    Molecular plant-microbe interactions : MPMI·1998
    Same author

    Erwinia amylovora secretes DspE, a pathogenicity factor and functional AvrE homolog, through the Hrp (type III secretion) pathway.

    Journal of bacteriology·1998
    Same journal

    A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes.

    Diabetes care·2026
    Same journal

    Clinical and Biochemical Recovery From Immune Checkpoint Inhibitor-Induced Diabetes With Seroconversion of GAD Antibodies.

    Diabetes care·2026
    Same journal

    State Insulin Out-of-Pocket Cap Policies and Estimated Eligible Populations in the United States, 2019-2026.

    Diabetes care·2026
    Same journal

    Genetic Determinants of Macronutrient Intake Are Associated With Specific Food Intake in Youth: A Cohort Study Across Childhood and Adolescence.

    Diabetes care·2026
    Same journal

    A Novel Electronic Medical Record Search Method to Identify Patients With Ketosis-Prone Diabetes: Implications for Discovery of Atypical Diabetes.

    Diabetes care·2026
    Same journal

    Real-Time Continuous Glucose Monitoring Among People With Type 2 Diabetes and End-Stage Kidney Failure Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.

    Diabetes care·2026
    See all related articles

    Area of Science:

    • Health Services Research
    • Health Economics
    • Diabetes Management

    Background:

    • Third-party reimbursement for diabetes outpatient education and new healthcare technologies is a significant concern.
    • Existing reimbursement pathways are fragmented, requiring individual approaches to payers.
    • Variability exists in coverage based on insurance type, geographic location, and specific services/equipment.

    Purpose of the Study:

    • To analyze the current landscape of third-party reimbursement for diabetes outpatient education and technologies.
    • To review strategies employed by states and diabetes programs to secure reimbursement.
    • To provide recommendations for healthcare providers and educators seeking reimbursement.

    Main Methods:

    • Review of existing reimbursement successes across various insurance providers (Blue Cross/Blue Shield, commercial insurers, Medicare, Medicaid).

    Related Experiment Videos

  • Analysis of state-specific approaches and diabetes control program strategies.
  • Identification of common barriers and challenges in obtaining third-party payer coverage.

    • Main Results:

    • Reimbursement for outpatient diabetes education has been achieved through various private and public payers in multiple states.
    • Third-party coverage for diabetes technologies and services is highly variable and often lacks clear policies.
    • Insulin pumps and similar equipment frequently face inconsistent or unstated reimbursement standards.

    Conclusions:

    • Securing third-party reimbursement for diabetes care requires persistent, individualized efforts.
    • Clearer, more consistent payer policies are needed for diabetes outpatient education and advanced technologies.
    • Developing standardized approaches and advocating for policy changes can improve access to essential diabetes management resources.